Clinitech Laboratory Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2026 ,inter alia, to consider and approve To consider and approve ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Clinitech Laboratory Ltd has informed BSE that a Board meeting is scheduled for May 28, 2026 via video conferencing. The meeting will consider and approve the Audited Standalone and Consolidated Financial Statements along with Auditor's Report for the half year and financial year ended March 31, 2026. Additionally, the Board will review the internal audit report for the year and note related party transactions. The trading window has been closed from April 1, 2026 and will remain closed till 48 hours after the results announcement. This is a routine quarterly/annual results meeting pursuant to SEBI LODR regulations.
This is a standard pre-results announcement notice. Once the financial results are approved and announced on May 28, 2026, the trading window will reopen, potentially triggering increased volatility or trading activity in the stock.